In the summer of 2017, myself and Manasa Prahlad researched how to induce exon skipping to treat Duchenne muscular dystrophy. We worked in the Chasin Lab on the main campus. Our research spanned the topics of genetics, biochemistry, biology, and chemistry. We aimed to create a plasmid that contained both the gene of interest, dhfr, our exon of interest, Exon 51, and a marker of successful transfection, the puromycin resistance gene. We successfully created this plasmid, which we then used to analyze its splicing efficiency.